Haleon UK Holding Sri Lanka Limited

Active09400298 Private limited company
Incorporated
21 January 2015 (11 years)
Previously known as
Glaxosmithkline Consumer Healthcare Sri Lanka Holdings Limited (until 14 April 2023)
This list may be incomplete. See all names on Companies House
Industry
Activities of other holding companies n.e.c. (64209)
Accounts type
Audit exemption subsidiary
Region
South East
Address
Building 5
First Floor
The Heights
Weybridge
KT13 0NY

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
30 August 2027
Last conf. stmt
16 August 2026

Officers 4 active

Officer details are public data from the Companies House register.

Officer history (13 former)
29 January 2024
Resigned Agnew, Rebecca Jane as Director
6 April 2022
Resigned Edinburgh Pharmaceutical Industries Limited as Corporate Secretary
6 April 2022
Appointed Haleon UK Corporate Director Limited as Corporate Director
6 April 2022
Appointed Haleon UK Corporate Secretary Limited as Corporate Director
6 April 2022
Appointed Haleon UK Corporate Secretary Limited as Corporate Secretary
6 April 2022
Resigned The Wellcome Foundation Limited as Corporate Director
6 April 2022
Resigned Glaxo Group Limited as Corporate Director
4 March 2022
Resigned Cooper, Nicholas Ian as Director
4 March 2022
Resigned Cottam, David John as Director
4 March 2022
Appointed Agnew, Rebecca Jane as Director
4 March 2022
Appointed Di Pietro, Lee as Director
31 July 2020
Appointed Cottam, David John as Director
31 July 2020
Resigned Aristidou, Antrinkos Andrew as Director
10 March 2020
Resigned Tattershall, Richard Philip as Director
10 March 2020
Resigned Green, Richard as Director
11 September 2019
Appointed Cooper, Nicholas Ian as Director
19 August 2019
Appointed Aristidou, Antrinkos Andrew as Director
15 January 2019
Appointed Green, Richard as Director
15 January 2019
Resigned Foster-Hawes, Melanie as Director
30 November 2017
Appointed Tattershall, Richard Philip as Director
30 November 2017
Resigned Box, Jonathan Wilson as Director
1 August 2016
Resigned Walker, Adam as Director
17 June 2016
Appointed Foster-Hawes, Melanie as Director
17 June 2016
Appointed Box, Jonathan Wilson as Director
1 March 2016
Resigned Blackburn, Paul Frederick as Director
3 June 2015
Appointed Walker, Adam as Director
21 January 2015
Appointed Blackburn, Paul Frederick as Director
21 January 2015
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Secretary
21 January 2015
Appointed Glaxo Group Limited as Corporate Director
21 January 2015
Appointed The Wellcome Foundation Limited as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 09237639

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
19 August 2026Confirmation statement with no updates16 August 2026
25 April 2026Other filing
25 April 2026Other filing
25 April 2026Accounts filing
25 April 2026Audit exemption subsidiary accounts31 December 2025
Show all recent filings

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?